Neuronal Antibody Panel (Paraneoplastic Syndrome)

The Neuronal Antibody Panel (Paraneoplastic Syndrome) is a blood test that helps in the diagnosis of paraneoplastic syndromes, a rare group of disorders that develop due to the body's immune system attacking healthy cells and tissues in response to a cancerous tumour. This panel includes multiple tests that identify the presence of autoantibodies that target various neurons and neural pathways.

These autoantibodies can cause a wide range of neurological symptoms such as difficulty in movement, muscle weakness, vision disturbances, and cognitive impairment. The Neuronal Antibody Panel (Paraneoplastic Syndrome) is an essential test for patients who are suspected to have an underlying tumour and are experiencing neurological symptoms. Early detection and treatment of paraneoplastic syndromes can improve the patient's outcome and quality of life.

The panel includes several tests, including Anti-Hu, Anti-Ri, Anti-Yo, Anti-Ma2, Anti-CV2, and Anti-amphiphysin. The Anti-Hu antibody is commonly associated with small cell lung cancer, and the Anti-Ri antibody is associated with breast or ovarian cancer. Anti-Yo antibody is linked with gynaecological tumours, Anti-Ma2 antibody is linked with testicular or lung cancer, Anti-CV2 antibody is linked with thymoma or other cancers, and Anti-amphiphysin antibody is linked with breast cancer or lung cancer. The presence of these antibodies in the blood indicates a higher likelihood of an underlying tumour and the need for further diagnostic workup.

healthcare nt sickcare offers the Neuronal Antibody Panel (Paraneoplastic Syndrome) at an affordable cost, and the test can be easily booked online through our user-friendly website. Our in-house medical laboratory is equipped with state-of-the-art technology to ensure accurate and reliable results. Our team of experienced healthcare professionals ensures that the testing process is comfortable and stress-free for patients. The results of the test will be provided within a quick turnaround time, enabling physicians to begin treatment promptly.